Coffee reduces KRAS expression in Caco-2 human colon carcinoma cells via regulation of miRNAs
Authors:
Open Access
- 22 May 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 1109-1114
Abstract
Previous epidemiological studies have demonstrated that moderate coffee consumption is associated with a lower risk of certain types of cancer, particularly colon cancer. To elucidate the molecular basis for this protective action, the effect of coffee on Caco-2 human colon carcinoma cells was investigated. Low concentrations of coffee (<5%) inhibited proliferation of Caco-2 cells without affecting cell viability. Coffee also reduced KRAS proto-oncogene, GTPase (KRAS) gene expression in a dose-dependent manner; however, caffeine, caffeic acid and chlorogenic acid, three major constituents of coffee, did not exhibit this effect. Increasing the duration of coffee bean roasting increased the reduction in KRAS expression, suggesting that the active constituents responsible for this effect emerged during the roasting process. MicroRNA (miR) analysis revealed that coffee induced the expression of miR-30c and miR-96, both of which target the KRAS gene. The results of the present study suggested that daily coffee consumption may reduce KRAS activity, thereby preventing the malignant growth of colon carcinoma cells.Keywords
This publication has 30 references indexed in Scilit:
- TP53 and Let-7a micro-RNA Regulate K-Ras Activity in HCT116 Colorectal Cancer CellsPLOS ONE, 2013
- MicroRNA let-7a Inhibits the Proliferation and Invasion of Nonsmall Cell Lung Cancer Cell Line 95D by Regulating K-Ras and HMGA2 Gene ExpressionCancer Biotherapy and Radiopharmaceuticals, 2013
- Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS OncogenePLOS ONE, 2012
- Coffee consumption and risk of cancers: a meta-analysis of cohort studiesBMC Cancer, 2011
- Onconase mediated NFKβ downregulation in malignant pleural mesotheliomaOncogene, 2011
- Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPKCarcinogenesis, 2011
- Coffee consumption and risk of colorectal cancer: a meta-analysis of case–control studiesCancer Causes & Control, 2010
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Coffee drinking and hepatocellular carcinoma riskHepatology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001